WuXi Biologics (Cayman) revenue and financials

2269 · HKEX · HKD

Compare WuXi Biologics (Cayman)
$43.98Change from previous close: −5.01%Absolute change: −$2.32

Close · November 18, 2026

In the fiscal year ended December 2025, WuXi Biologics (Cayman) reported revenue of ¥21.79B (+16.68% year over year). Net income was ¥4.91B, a net margin of 22.5%.

Annual revenue · 2025: ¥21.79B
  1. ¥989.03M2016
  2. ¥1.62B2017
  3. ¥2.53B2018
  4. ¥3.98B2019
  5. ¥5.61B2020
  6. ¥10.29B2021
  7. ¥15.27B2022
  8. ¥17.03B2023
  9. ¥18.68B2024
  10. ¥21.79B2025

Fiscal year ending in December. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
+16.68%
2025 vs 2024
Net income growth
+46.25%
2025 vs 2024
Net margin
22.5%
2024: 18.0%

How WuXi Biologics (Cayman) is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of CNY; per-share values in CNY; shares in millions.

Income statement · Annual
Item2025202420232022202120202019201820172016
Total revenue21,79018,67517,03415,26910,2905,6123,9842,5341,619989
Cost of revenue11,77211,02510,2068,5455,4613,0792,3251,517958600
Gross profit10,0197,6516,8286,7244,8292,5331,6591,018661389
Selling, general and administrative2,5192,2992,0861,6931,133722451326175110
Research and development85376678668350230426016974.553.3
Operating income6,6464,5853,9334,3503,1701,502948522411226
EBIT6,6464,5853,9334,3503,1701,502948522411226
EBITDA7,9255,8494,9285,0693,6221,7711,141664498319
Interest expense14315815864.439.242.719.6—35.724.2
Pre-tax income7,2574,8344,1745,3583,9931,9661,127738304176
Income tax1,52488960380848527311610751.134.8
Net income4,9083,3563,4004,4203,3881,6891,014631253141
Net income to common shareholders4,9083,3563,4004,4203,3881,6891,014631253141
Basic EPS1.220.820.821.060.810.430.270.170.080.05
Diluted EPS1.160.780.771.010.770.400.250.160.070.05
Average shares (basic)4,0274,0824,1644,1734,1743,9533,7173,6323,2222,892
Average shares (diluted)4,1764,2274,3494,3764,4224,2093,9973,9423,4812,892

Companies in the group: same industry, similar size